BL

Bastide le Confort Medical SAPAR Bastide le Stock Report

Last reporting period 31 Dec, 2023

Updated 04 Nov, 2024

Last price

Market cap $B

0.167

Micro

Exchange

XPAR - Euronext Paris

View Section: Company Analysis

Bastide le Rating

BL

BLC.PA stock rating score is 28/100. Bastide le is aExtremely Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

Last update 01.04.2024

28/100

Low score

Rating Breakdown

  • Profitability score

    22

    /25

  • Solvency score

    -3

    /25

  • Efficiency score

    8

    /25

  • Stability score

    1

    /25

Bastide le Confort Medical SA Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

1 %

Earnings quality

1285 %

Gross Margin

51 %

Bastide le Confort Medical SA's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation